CTI BioPharma Corp. Interest Expense 2011-2026 | CTIC

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense CTI BioPharma Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
13.1 M	2.42 M	828 K	1 M	1.21 M	1.87 M	2.61 M	2.1 M	1.95 M	1.03 M	56 K	870 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.1 M	56 K	2.42 M

Quarterly Interest Expense CTI BioPharma Corp.

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.18 M	-	3.56 M	3.76 M	2.06 M	-	653 K	167 K	187 K	-	115 K	137 K	167 K	-	240 K	269 K	294 K	-	308 K	297 K	288 K	-	457 K	488 K	534 K	-	634 K	677 K	714 K	-	1.29 M	597 K	494 K	-	472 K	467 K	464 K	-	316 K	316 K	48 K	-	43 K	3 K	5 K	-	161 K	222 K	389 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.18 M	3 K	689 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Autolus Therapeutics plc AUTL	9.29 M	$ 1.37	-8.67 %	$ 350 M	Britain
Aeglea BioTherapeutics AGLE	-20.7 M	-	-	$ 1.01 B	USA
Adagene ADAG	1.11 M	$ 1.65	6.11 %	$ 92.9 M	China
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.43	-2.69 %	$ 8.25 B	Australia
Biogen BIIB	250 M	$ 177.93	-4.15 %	$ 25.9 B	USA
Arrowhead Pharmaceuticals ARWR	5.26 M	$ 65.89	-0.06 %	$ 8.81 B	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
BeiGene, Ltd. BGNE	-12.6 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	2.66 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Ascendis Pharma A/S ASND	65.5 M	$ 214.55	2.77 %	$ 5 B	Danmark
Codiak BioSciences CDAK	2.7 M	-	-55.98 %	$ 2.15 M	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Bristol-Myers Squibb Company BMY	-893 M	$ 55.84	0.13 %	$ 113 B	USA
Cerevel Therapeutics Holdings CERE	10.6 M	-	-	$ 7.29 B	USA
Caladrius Biosciences CLBS	-257 K	-	-16.75 %	$ 25.8 M	USA
BioLineRx Ltd. BLRX	9.07 M	$ 2.86	-	$ 908 M	Israel
Chimerix CMRX	11 M	-	-	$ 756 M	USA
Adaptimmune Therapeutics plc ADAP	-807 K	-	-15.15 %	$ 60.3 M	Britain
Can-Fite BioPharma Ltd. CANF	227 K	$ 4.18	-1.65 %	$ 9.1 B	Israel
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Catalyst Biosciences CBIO	1.04 M	$ 11.09	1.0 %	$ 730 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Coherus BioSciences CHRS	40.5 M	$ 1.69	2.12 %	$ 159 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	4.08 M	$ 28.99	-1.39 %	$ 1.4 B	USA
Celldex Therapeutics CLDX	927 K	$ 25.71	0.16 %	$ 1.66 M	USA
Cellectis S.A. CLLS	371 K	$ 4.24	-0.47 %	$ 116 M	France
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA